Announcements Trials
Browse Landscape

Status

Recruiting 5Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER_GOV 1OTHER 1

Study Type

Interventional 35Observational 8

Sponsor

Cancer Type

Genitourinary 8

Conditions

Prostatic Neoplasms 4Non-metastatic Castration-resistant Prostate Cancer 2Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2Sleep Initiation and Maintenance Disorders 1Fatigue 1Depression 1

Interventions

Surveys and Questionnaires 53Blood Specimen Collection 53Specimen Handling 28Radiotherapy 18Observation 18Interviews as Topic 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 10Drug Therapy 10Data Collection 10Biopsy 10Tomography, X-Ray Computed 9darolutamide 8Watchful Waiting 7Standard of Care 7ribociclib 6palbociclib 6Restraint, Physical 6Patient Reported Outcome Measures 6Magnetic Resonance Imaging 6Immune Checkpoint Inhibitors 6trastuzumab deruxtecan 5Positron-Emission Tomography 5Mass Screening 5Genetic Testing 5Esophagectomy 5Breath Tests 5Bevacizumab 5enzalutamide 4apalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Observational × darolutamide × 90 days × Clear all
NCT07395804 2026-05-26

23146

Bayer

Recruiting
500 enrolled
Genitourinary

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06661122 2026-05-19

HAYATE

Bayer

Recruiting
100 enrolled
Genitourinary

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07538843 2026-05-15

DARE

Bayer

Not yet recruiting
800 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT06334120 2026-05-13

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Bayer

Recruiting
600 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT07181122 2026-04-28

PRO-MIND

Ankara Etlik City Hospital

Recruiting
102 enrolled
Genitourinary

Depression, Fatigue, Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms

NCT07406282 2026-04-09

Double-DARE

Bayer

Recruiting
1,400 enrolled
Genitourinary

Prostatic Neoplasms

NCT07344779 2026-04-03

ROAD

Bayer

Active not recruiting
1,600 enrolled
Genitourinary

Prostatic Neoplasms

NCT07428642 2026-03-18

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

First Affiliated Hospital of Wenzhou Medical University

Completed
168 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡